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Background
HIV/AIDS infection is one of the priority issues of public
health both globally as well as in Republic of Moldova.
The negative impact of late presentation and detection is
important for the health system, by increasing mortality
and morbidity through requiring additional resources
and for the community by transmission of HIV.
Methods
We assessed 149 treatment-naïve patients with HIV/AIDS
who initiated HAART in 2011-2012. The age of patients
included in this study were between 18 and 77 years
(36.3±0.8 years), out of which 60% were young people
between 30 and 39 years. Late diagnosis was defined as
the presence of AIDS related diseases and/or CD4 <350
cells/cmm.
Results
The following modes of transmission were identified: het-
erosexual – 130 (87.3%) patients and IDUs (injecting
drug use) – 19 (12.7%) patients. Out of 149 patients, 94
(63.1%) patients were detected late with CD4 counts
<350 cells/cmm, out of which 56 (59.6%) patients were
detected very late with CD4 counts <200 cells/cmm.
HIV/AIDS infection was diagnosed during the period
1997-2011, and HAART was initiated in 2011. The per-
iod from detection of HIV infection to HAART initiation
was less than 1 year to 1/3 of all patients – 47 (31.6%),
1 year – 21 (14.1%), 2 years – 15 (10.1%), 3 years –
20 (13.4%), 4 years – 15 (10.1%), 5 years – 10 (6.7%),
6 years – 5 (3.3%), 7 years – 6 (4%), 9 years – 2 (1.3%),
10 years – 1 (0.7%), 11 years – 3 (2%), 13 years – 3 (2%)
and 14 years – 1 (0.7%). The average CD4 cell count at
detection of HIV infection was 283.54±16.2 cells/cmm,
and lower at initiation of HAART (220.5±11.3 cells/
cmm), (p <0.01). At detection of HIV infection approxi-
mately 1/3 of patients (30.9%) had viral load >100000
copies/mL.
Conclusion
About 2/3 (63.1%) of patients with HIV/AIDS are detected
late, compared to 15-38% of the cases in the European
Union, thus it is necessary to improve HIV testing strate-
gies. The route of transmission of HIV infection was het-
erosexual – 87.3% and through injecting drug use –
12.7%. It was established that at the start of HAART the
most common opportunistic infections were oropharyn-
geal candidiasis – 82 (55%) patients, tuberculosis –
34 (22.8%), wasting syndrome - 19 (13.1%), herpes zoster
– 12 (8.3%), Kaposi’s sarcoma – 4 (2.8%). At the initiation
of HAART 110 (73.8%) were diagnosed with AIDS.
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